Labshake search
Citations for R&D Systems :
5801 - 5850 of 10000+ citations since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2022Quote: ... A Galectin-7 ELISA kit (R&D Systems) was used to measure its concentration in the plasma of patients.
-
bioRxiv - Cancer Biology 2022Quote: ... and TGF-β1 were purchased from R&D systems and reconstituted according to manufacturer instructions ...
-
bioRxiv - Cancer Biology 2022Quote: IL-6 secretion was measured using a Human IL-6 Quantikine ELISA Kit (R&D systems, #D6050) per manufacturer’s instructions.
-
bioRxiv - Cancer Biology 2022Quote: ... 100ng/mL human FGF (R&D Systems, 233-FB), 10nM human gastrin I (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... 10nM human gastrin I (R&D Systems, 3006/1), 500nM A83-01 (Selleckchem ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 1μM PGE2 (R&D Systems, 2296/10).
-
bioRxiv - Cancer Biology 2022Quote: ... 50ng/mL hEGF (R&D Systems, 236EG200), 100ng/mL human FGF (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: Hepsin (0.05 μM) (R&D Systems, Madrid, Spain) was incubated in 50 mM Tris-HCl buffer ...
-
bioRxiv - Cancer Biology 2022Quote: ... were plated in HITES media in the following conditions: 10 μg/mL Fibronectin (Cat no. 1918-FN-02M, R&D Systems) coated ...
-
bioRxiv - Cancer Biology 2022Quote: ... 22Rv1 cells expressing dox-inducible shNT or shUGUUUGC shRNAs were mixed with 50% basement membrane extract (R&D Systems, Minneapolis, MN, USA) and injected subcutaneously into the flanks (3×106 cell per injection) ...
-
bioRxiv - Cancer Biology 2022Quote: ... Slides were processed with a commercial DAB cell and tissue staining kit (#CTS019, R&D Systems). Primary antibody immunostaining was optimised for polyclonal rabbit anti-human peroxidasin (#abx101905 ...
-
bioRxiv - Cancer Biology 2022Quote: ... Serum-starved cells were stimulated with human recombinant TGFβ1 (R&D Systems) for 16h.
-
bioRxiv - Bioengineering 2022Quote: ... OTX2 (goat, R&D Systems, 1:100), and PAX6 antibodies (mouse ...
-
bioRxiv - Cancer Biology 2022Quote: ... 20ng/μL IL-18 (R&D Systems), 5μM ribociclib (Selleck Chemicals) ...
-
bioRxiv - Cancer Biology 2022Quote: ... in PBS and blocked for 10 mins after which the cells were collected and resuspended in 100 µl 1% BSA/PBS containing 2 µl of antibodies SLAMF1/CD150-PE (R&D Systems) or GRPC5C Alexa Fluor-405 (R&D Systems ...
-
bioRxiv - Cancer Biology 2022Quote: ... human cytokines (1 ng/ml stem cell factor, 100 ng/ml thrombopoietin, 13.5 ng/ml interleukin 9, 10 ng/ml interleukin 6; all cytokines from R&D Systems), and 1XPenicillin-Streptomycin (Gibco ...
-
bioRxiv - Cancer Biology 2022Quote: ... and NCAM-PE (R&D Systems FAB7820P, 1:100) (Shue et al. ...
-
bioRxiv - Cancer Biology 2022Quote: Human cytokine secretion was assessed in mouse plasma samples using the Human XL Cytokine Luminex Performance Panel Premixed Kit (#FCSTM18, R&D Systems), according to the manufacturer’s instructions.
-
bioRxiv - Biophysics 2022Quote: ... Serial dilutions of hexahistidine-tagged LRP6 domains or Reck (R&D systems) were prepared in ELISA buffer (PBS ...
-
bioRxiv - Biophysics 2022Quote: ... the cells were treated with 20 – 100 U/ml IFN-γ (R&D Systems) and 1 μM TPI peptide (Genscript ...
-
bioRxiv - Cancer Biology 2022Quote: ... or GRPC5C Alexa Fluor-405 (R&D Systems) and incubated on ice in the dark for 30 mins ...
-
bioRxiv - Cancer Biology 2022Quote: ... Anti-CD150-PE and anti-GRPC5C Alexa Fluor-405 antibodies were purchased from R&D Systems. Transforming growth factor beta-1 (TGFb-1 ...
-
bioRxiv - Biophysics 2022Quote: ... supplemented with 10% fetal bovine serum (FBS) (R&D Systems, S11150) and penicillin/streptomycin (Gibco,15070063) ...
-
bioRxiv - Bioengineering 2022Quote: ... Sox9 (1:20 dilution; R&D Systems, AF3075), MUC5ac (1:200 dilution ...
-
bioRxiv - Biochemistry 2022Quote: ... The peptides were serially diluted in assay buffer (PBS + 0.05 mg/mL BSA) that contained 0.16% TEA to appropriate concentrations and were preincubated with Fc-Spike-RBD (R&D Systems, Cat. No. 10542-CV-100) at 37 °C for 1 hour (12.5 μL total volume) ...
-
bioRxiv - Bioengineering 2022Quote: ... recombinant BMP-2 (R&D Systems, Minneapolis, MN) at varying doses (0 ...
-
bioRxiv - Cancer Biology 2022Quote: ... EGFR-A488 (R&D Systems, FAB10951G), CD45RA-ECD (Beckman Coulter ...
-
bioRxiv - Cancer Biology 2022Quote: ... EGFR-A488 (R&D Systems, FAB10951G), CD279 (PD1)-PE (Miltenyi Biotech ...
-
bioRxiv - Cancer Biology 2022Quote: ... EGFR-A488 (R&D Systems, FAB10951G), CD19-ECD (Beckman Coulter ...
-
bioRxiv - Cancer Biology 2022Quote: ... with an anti-EGFR-FITC antibody (R&D Systems, FAB10951G).
-
bioRxiv - Cancer Biology 2022Quote: ... Specificity of staining was confirmed with the rat IgG isotype control (R&D Systems, #6-001-F). Brightfield images were acquired with a NanoZoomer-2.0 HT C9600 digital scanner (Hamamatsu ...
-
bioRxiv - Cancer Biology 2022Quote: ... and for the release of IL2 by ELISA (R&D Systems). Infected myeloid cells were selected by the addition of puromycin 1μg/ml for 2 weeks ...
-
bioRxiv - Cancer Biology 2022Quote: ... and ELISA (R&D Systems).
-
bioRxiv - Cancer Biology 2022Quote: ... MCP-1 (cat#AB279) and isotype specific control were purchased from R&D systems and used at a concentration for 100μg/ml ...
-
bioRxiv - Cancer Biology 2022Quote: ... interferon-β treatments were performed at a concentration of 1000U/mL for 24 hours (R&D systems Inc., Minneapolis, MN). When siRNA transfections were performed for a 72 hour total duration ...
-
bioRxiv - Cancer Biology 2022Quote: ... anti-mouse Oncostatin M (R&D systems), anti-mouse IL-6 (BioxCell) ...
-
bioRxiv - Bioengineering 2022Quote: ... Enzyme-Linked Immunosorbent Assay (ELISA) kit (DuoSet ELISA Ancillary Reagent Kit and Human Lubricin/PRG4 kit, R&D systems) was used following manufacturer’s protocol ...
-
ALiCE®: A versatile, high yielding and scalable eukaryotic cell-free protein synthesis (CFPS) systembioRxiv - Biochemistry 2022Quote: Anti-RBD antibodies were procured to recognise either linear or conformation epitopes (MAB10540 and MAB105802, respectively; R&D Systems). Serum samples were collected either from COVID-19 patients with a positive PCR test in 2020 or prior to 2019 as negative controls ...
-
bioRxiv - Biochemistry 2022Quote: ... Anti-EPCAM (AF960) and Anti-AMPN (AF3815) antibodies were from R&D Systems. Antibodies against β-actin (sc-47778) ...
-
bioRxiv - Biochemistry 2022Quote: ... Cat #: 6418-GR) was obtained from R&D Systems, Inc ...
-
bioRxiv - Biochemistry 2022Quote: ... Mex67 and Hpr1 were HA-tagged and detected with an anti-HA antibody fused with HRP (R&D Systems). The antibody directed against Sto1 / Cbp80 is a kind gift of D ...
-
bioRxiv - Bioengineering 2022Quote: ... with or without recombinant DKK1 or RSPO2 (R&D Systems) as indicated in Results ...
-
bioRxiv - Bioengineering 2022Quote: ... anti-TGF-β1 IgY-Biotin (R&D Systems, Minneapolis, MN), anti-hIgG-HRP (Jackson ImmunoResearch Inc. ...
-
bioRxiv - Bioengineering 2022Quote: The presence of selected cytokines was evaluated in samples of conditioned medium with Proteome profiler human angiogenesis array (R&D Systems) according to the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2022Quote: ... Cyagen sourced MSCs were cultured in StemXVivo mesenchymal stem cell expansion media (R&D systems, Toronto, ON, Canada) inside tissue culture incubators at 37°C with 5% CO2 ...
-
bioRxiv - Bioengineering 2022Quote: The preosteoblast cells cultured in tissue culture plates were differentiated for 5 days and treated with Myostatin of 100 ng/mL (788-G8-010/CF R&D system), follistatin of 100 ng/mL (769-FS-025/CF ...
-
bioRxiv - Bioengineering 2022Quote: ... 1000 ng/mL Slit (R&D Systems, 5199-SL-050), and 10 ...
-
bioRxiv - Bioengineering 2022Quote: ... we used a Proteome Profiler Human Cytokine Array (R&D Systems) using the recommended protocol for cell supernatant ...
-
bioRxiv - Bioengineering 2022Quote: ... Recombinant LOXL2 (R&D Systems) was used as a positive control.
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with 50 ng/mL recombinant human vascular endothelial growth factor (VEGF; R&D Systems), 10 μM Y-27632 ...